KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.77 $3.19 Friday, 26th Apr 2024 ATHE stock ended at $2.51. This is 11.06% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 21.68% from a day low at $2.26 to a day high of $2.75.
90 days $1.55 $3.19
52 weeks $1.55 $5.41

Historical Alterity Therapeutics Limited prices

Date Open High Low Close Volume
Apr 26, 2024 $2.26 $2.75 $2.26 $2.51 87 711
Apr 25, 2024 $2.30 $2.47 $2.26 $2.26 24 568
Apr 24, 2024 $2.14 $2.50 $2.14 $2.33 172 845
Apr 23, 2024 $2.10 $2.20 $2.04 $2.13 31 441
Apr 22, 2024 $2.00 $2.18 $2.00 $2.13 41 771
Apr 19, 2024 $2.08 $2.15 $2.01 $2.04 53 503
Apr 18, 2024 $1.97 $2.16 $1.97 $2.14 25 317
Apr 17, 2024 $2.05 $2.20 $1.91 $2.01 124 637
Apr 16, 2024 $2.45 $2.67 $1.96 $2.05 365 796
Apr 15, 2024 $2.69 $2.69 $2.23 $2.45 439 933
Apr 12, 2024 $2.83 $3.19 $2.57 $2.94 785 277
Apr 11, 2024 $2.24 $2.65 $1.94 $2.63 510 974
Apr 10, 2024 $1.93 $2.36 $1.88 $2.19 683 834
Apr 09, 2024 $1.86 $1.91 $1.86 $1.91 10 336
Apr 08, 2024 $1.91 $1.91 $1.85 $1.88 7 913
Apr 05, 2024 $1.87 $1.88 $1.85 $1.88 5 895
Apr 04, 2024 $1.84 $1.85 $1.82 $1.84 16 417
Apr 03, 2024 $1.84 $1.89 $1.80 $1.84 17 108
Apr 02, 2024 $1.92 $1.94 $1.81 $1.83 58 743
Apr 01, 2024 $2.05 $2.05 $1.90 $1.95 13 798
Mar 28, 2024 $2.02 $2.12 $1.96 $2.07 67 968
Mar 27, 2024 $1.77 $2.02 $1.77 $2.02 101 620
Mar 26, 2024 $1.75 $1.84 $1.71 $1.80 23 516
Mar 25, 2024 $1.70 $1.76 $1.70 $1.71 19 917
Mar 22, 2024 $1.74 $1.88 $1.73 $1.77 7 257
Click to get the best stock tips daily for free!

About Alterity Therapeutics Limited

Alterity Therapeutics Limited Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company ... ATHE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT